hero section gradient
14 handpicked stocks

Active Lifestyle Portfolio

Tap into the powerful consumer shift toward personal health and fitness with this carefully selected group of companies. Our team of analysts has chosen brands that are leading the wellness economy as it becomes an essential part of modern life.

Author avatar

Han Tan | Market Analyst

Published on June 18

Your Basket's Financial Footprint

Market capitalisation breakdown for the Active Lifestyle Portfolio basket.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more stable returns, tending to track broad-market performance.
  • Suitable as a core holding for diversified portfolios, offering steady exposure rather than a speculative, high-growth position.
  • Expect steady long-term value; large-cap weightings make explosive short-term gains unlikely, though gradual appreciation is plausible.
Total Market Cap
  • LULU: $21.51B

  • NKE: $101.05B

  • ONON: $14.01B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This collection targets the global megatrend of increased spending on health and wellness. We've focused on companies that profit from consumers prioritizing fitness, nutrition, and active living as essential rather than optional expenses in their daily routines.

2

What You Need to Know

These companies span the entire active lifestyle ecosystem—from athletic apparel and footwear to fitness centers, home workout equipment, and nutritional products. Many are integrating technology to create more personalized experiences, opening new revenue opportunities.

3

Why These Stocks

We've selected established brands with strong recognition alongside innovative newcomers disrupting the wellness space. Each company was chosen for its direct alignment with key aspects of active living and potential to benefit from the continued growth of health-conscious consumer behavior.

Why You'll Want to Watch These Stocks

💪

Resilient Consumer Spending

Health and fitness spending has proven remarkably durable even during economic downturns, as consumers increasingly view wellness as an essential, not a luxury.

📱

Tech-Powered Growth

The integration of wearable technology and personalized fitness apps is creating entirely new revenue streams and deeper customer relationships across this sector.

🌱

Just Getting Started

The wellness economy is still in its early growth stages, with younger generations spending significantly more on fitness and nutrition than previous ones did.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Global Infrastructure Partners: UAE Exposure Risks

Global Infrastructure Partners: UAE Exposure Risks

The UAE's strategic push for economic diversification and smart city development is creating significant demand for advanced construction and infrastructure solutions. This basket provides exposure to a selection of US and EU-listed companies that supply essential materials, technology, and engineering services to the region's projects.

UAE Infrastructure Global Suppliers Breakdown

UAE Infrastructure Global Suppliers Breakdown

As the UAE continues its ambitious economic diversification, demand for world-class infrastructure creates opportunities for the companies that build it. This basket offers exposure to US and EU-listed industrial, materials, and technology firms that are integral to developing these large-scale projects.

Antiviral M&A Wave: Biotech Opportunities in 2025

Antiviral M&A Wave: Biotech Opportunities in 2025

Merck's $9.2 billion acquisition of Cidara Therapeutics strengthens its antiviral pipeline as a key patent nears expiry. This major deal signals a growing trend of pharmaceutical giants buying smaller biotechs, creating potential opportunities among companies with promising infectious disease therapies.

Frequently Asked Questions